14 January 2011
Smiths Group confirms that it has received an approach for Smiths Medical which it has rejected.
The value offered was £2.45 billion in cash, as a best and final offer, subject inter alia, to extensive due diligence and completion of financing.
The Board has carefully considered this approach with its advisers and has concluded that it would not be in the interests of shareholders to pursue discussions on the basis of an indication at this price level.
In reaching this conclusion, the Board has taken into account the quality and highly cash generative nature of Smiths Medical, both standalone and in the context of the Group as a whole.
General media enquiries
Contact our global media and communications team at:

Please note – the press team can only answer enquiries from accredited members of the press.
Related articles

John Crane unveils game-changing mechanical seal, setting new benchmark for ethane pipeline performance
Read our company news as John Crane has launched a new mechanical seal
Find out more![Davinci Gen V Banner Iamge[39]](/media/whpf0qko/davinci-gen-v-banner-iamge-39.jpg?width=431&height=214&format=webp&quality=100&v=1dbb81c2443a690)
Smiths Interconnect announces significant contract win
Read our company news as Smiths Interconnect announces a significant contract win
Find out more